Combination Vaccine Clinical Trials — Safety Data

Combination vaccine clinical trials and safety data — reviewing pre-licensure testing methodology, adverse event findings, and trial design for ProQuad, Pediarix, Pentacel, Kinrix, and Vaxelis.

Clinical trial data for the multi-antigen combination vaccines on the US schedule. All combination vaccines were licensed against a combination of their component vaccines or other active vaccines — never against an inert placebo. Because each individual component was never placebo-controlled, the combination's safety inherits all the deficits of its parts. The combined biological effect of administering multiple antigens simultaneously has never been studied against a no-vaccine control.

Pediarix (GSK) — DTaP + HepB + IPV

Source: FDA-approved package insert.

Each component in the control arm had its own separate safety limitation: Engerix-B was licensed with 4-day monitoring, IPOL with 3-day monitoring, Infanrix with DTP as its control. The safety of Pediarix as a combined product rests on the accumulated inadequacy of all three component licensure trials.

Pentacel (Sanofi) — DTaP + Hib + IPV

Source: FDA-approved package insert.

Five separate components used as controls, none placebo-controlled.

Vaxelis (MSP Vaccine) — DTaP + Hib + IPV + HepB

Source: FDA-approved package insert.

Vaxelis adds HepB to the Pentacel combination; all control products trace back to inadequate pre-licensure trials. MSP Vaccine is a Merck-Sanofi joint venture.

ProQuad (Merck) — MMRV

Source: FDA-approved package insert.

MMR-II was licensed with no control group (834 children, 42-day window). Varivax was licensed against a neomycin injection falsely labeled "placebo" (465 children). ProQuad is "as safe as" combining two vaccines, neither of which was placebo-controlled. See MMR Vaccines (Pre-Licensure) and Varicella Vaccines (Pre-Licensure).

Kinrix (GSK) — DTaP + IPV (4–6 year booster)

Source: FDA-approved package insert.

Infanrix was licensed against DTP (a vaccine shown to increase infant mortality); IPOL was licensed with no control and 3-day monitoring.

Quadracel (Sanofi) — DTaP + IPV (4–6 year booster)

Source: FDA-approved package insert.

Daptacel was licensed with a 3.9% SAE rate in infants vs. a DTP control. See DTaP Vaccines (Pre-Licensure).

Penbraya (Pfizer) — MenABCWY

Source: FDA-approved package insert.

Both components in the control arm are themselves not placebo-controlled. See MenACWY Vaccines (Pre-Licensure).

Summary Table

The Combination Compounding Problem

Combination vaccines introduce a unique compounding safety problem:

1. No individual placebo baselines: Each component was never tested against a true placebo

2. No combination-specific placebo: The combination is tested against its components administered separately — not against a placebo

3. Unknown interaction effects: Combining multiple antigens and adjuvants in a single injection may produce immune or biological interactions that did not occur when components were administered separately

4. No concurrent-administration trial: At a 2-month well-child visit, an infant may receive Pediarix + Hib + PCV — five antigens in one sitting. The combined safety of this concurrent administration has never been studied against a true placebo

Schedule

Combination products are substituted for individual components at applicable well-child visits. At a typical 2-month visit, a child may receive Pediarix (DTaP + HepB + IPV) plus Hib plus PCV plus oral Rotavirus — multiple antigens in one sitting. See Childhood Vaccine Schedule.

Disease Context

Each combination product targets the diseases of its component antigens. See the individual vaccine pages: DTaP Vaccines (Pre-Licensure), Hepatitis B Vaccines (Pre-Licensure), IPV Vaccines (Pre-Licensure), Hib Vaccines (Pre-Licensure), MMR Vaccines (Pre-Licensure), Varicella Vaccines (Pre-Licensure), MenACWY Vaccines (Pre-Licensure).

See Also

Combination Vaccines (Post-Licensure), Pre-Licensure Safety Testing, DTaP Vaccines (Pre-Licensure), Hib Vaccines (Pre-Licensure), IPV Vaccines (Pre-Licensure), MMR Vaccines (Pre-Licensure), Varicella Vaccines (Pre-Licensure), Hepatitis B Vaccines (Pre-Licensure), MenACWY Vaccines (Pre-Licensure), Henry Ford Vaccinated vs. Unvaccinated Study, Childhood Vaccine Schedule, GSK, Sanofi, Merck, Pfizer

Frequently Asked Questions

This is the plain-HTML rendering of vaccines/pre-licensure/Combination Vaccines.md, served for search engines, AI crawlers, and accessibility tools. The interactive 3D version of this wiki lives at vaccine-safety.org.